We describe a case of cardiac toxoplasmosis diagnosed by routine endomyocardial biopsy in a patient with trimethoprim-sulfamethoxazole (TMP-SMX) intolerance on atovaquone prophylaxis. Data are not available on the efficacy of atovaquone as Toxoplasma gondii prophylaxis after heart transplantation. In heart transplant patients in whom TMP-SMX is not an option, other strategies may be considered, including the addition of pyrimethamine to atovaquone.
Keywords: Toxoplasma gondii; diagnosis; endomyocardial biopsy; heart transplantation; prophylaxis; toxoplasmosis.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.